Cargando…

Rainbow of KIBOU (ROK) study: a Breast Cancer Survivor Cohort in Japan

BACKGROUND: Although there are a large number of epidemiological studies investigating the etiological role of lifestyle factors in breast cancer, there are few studies on the association between lifestyle factors and breast cancer prognosis. To investigate the influence of lifestyle factors such as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mizota, Yuri, Ohashi, Yasuo, Iwase, Takuji, Iwata, Hiroji, Sawaki, Masataka, Kinoshita, Takayuki, Taira, Naruto, Mukai, Hirofumi, Yamamoto, Seiichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741795/ https://www.ncbi.nlm.nih.gov/pubmed/28547387 http://dx.doi.org/10.1007/s12282-017-0784-x

Ejemplares similares

ROK study-C (Rainbow of KIBOU study-colorectum): a colorectal cancer survivor cohort study on food, nutrition, physical activity, psychosocial factors and its influences on colorectal cancer recurrence, survival and quality of life in Japan
por: Mizota, Yuri, et al.
Publicado: (2018)

Cost-Effectiveness of Trastuzumab With or Without Chemotherapy as Adjuvant Therapy in HER2-Positive Elderly Breast Cancer Patients: A Randomized, Open-Label Clinical Trial, the RESPECT Trial
por: Takumoto, Yuki, et al.
Publicado: (2022)

Characterization of DNA Binding Sites of RokB, a ROK-Family Regulator from Streptomyces coelicolor Reveals the RokB Regulon
por: Bekiesch, Paulina, et al.
Publicado: (2016)

Real-world treatment patterns of subsequent therapy after palbociclib in patients with advanced breast cancer in Japan
por: Sawaki, Masataka, et al.
Publicado: (2023)

Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC Study
por: Hagiwara, Yasuhiro, et al.
Publicado: (2017)

Adjuvant trastuzumab without chemotherapy for treating early HER2-positive breast cancer in older patients: A propensity score-adjusted analysis of a prospective cohort study
por: Sawaki, Masataka, et al.
Publicado: (2022)

Prospective Cohort Study of Palbociclib Treatment in Postmenopausal Patients With Unresectable and Metastatic Hormone Receptor-Positive Breast Cancer: Study Protocol for a CSPOR-BC Palbociclib Cohort Trial
por: Narui, Kazutaka, et al.
Publicado: (2022)

Practice management for elderly patients with breast cancer; Findings from a survey by the Japan Breast Cancer Study Group
por: Sawaki, Masataka, et al.
Publicado: (2018)

Comparison of an AC‐taxane versus AC‐free regimen and paclitaxel versus docetaxel in patients with lymph node‐positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial, a randomized comparative phase 3 study
por: Watanabe, Toru, et al.
Publicado: (2017)

A case of giant cell tumor of the breast, clinically suspected as malignant breast tumor
por: Terada, Mitsuo, et al.
Publicado: (2019)

Overlapping Roles of Drosophila Drak and Rok Kinases in Epithelial Tissue Morphogenesis
por: Neubueser, Dagmar, et al.
Publicado: (2010)

ROK and Arteriolar Myogenic Tone Generation: Molecular Evidence in Health and Disease
por: El-Yazbi, Ahmed F., et al.
Publicado: (2017)

Dia- and Rok-dependent enrichment of capping proteins in a cortical region
por: Schmidt, Anja, et al.
Publicado: (2021)

Associations between earplug use and hearing loss in ROK military personnel
por: Kim, Hwi Jun, et al.
Publicado: (2021)

Association of change in health-related quality of life and treatment discontinuation in metastatic breast cancer: a post hoc, exploratory analysis of two randomized clinical trials
por: Kawahara, Takuya, et al.
Publicado: (2022)

Circulating tumor cells detection in tumor draining vein of breast cancer patients
por: Hattori, Masaya, et al.
Publicado: (2019)

Raf-1 sets the threshold of Fas sensitivity by modulating Rok-α signaling
por: Piazzolla, Daniela, et al.
Publicado: (2005)

Functional diversification of ROK-family transcriptional regulators of sugar catabolism in the Thermotogae phylum
por: Kazanov, Marat D., et al.
Publicado: (2013)

Operator recognition by the ROK transcription factor family members, NagC and Mlc
por: Bréchemier-Baey, Dominique, et al.
Publicado: (2015)

Epidemiology of SFTSV in Ticks collected from National Park in the ROK, 2015-2018
por: Cho, Yoon kyoung, et al.
Publicado: (2019)

How long should we continue gastric cancer screening? From an epidemiological point of view
por: Mizota, Yuri, et al.
Publicado: (2018)

No Association of the 5′Promoter Region Polymorphism of CYP17 with Breast Cancer Risk in Japan
por: Hamajima, Nobuyuki, et al.
Publicado: (2000)

Minimal important differences of EORTC QLQ-C30 for metastatic breast cancer patients: Results from a randomized clinical trial
por: Kawahara, Takuya, et al.
Publicado: (2022)

Venous thromboembolism in patients with cancer: design and rationale of a multicentre, prospective registry (Cancer-VTE Registry)
por: Ohashi, Yasuo, et al.
Publicado: (2018)

Evaluation of the Role of Axillary Lymph Node Fine-Needle Aspiration Cytology in Early Breast Cancer With or Without Neoadjuvant Chemotherapy
por: Takatsuka, Daiki, et al.
Publicado: (2023)

A pre-ribosomal RNA interaction network involving snoRNAs and the Rok1 helicase
por: Martin, Roman, et al.
Publicado: (2014)

Annual Disease Experience by Type and Correlations with Unmet Healthcare Needs among ROK Military Personnel
por: Kim, Hwi Jun, et al.
Publicado: (2020)

Bone Scan Index predicts skeletal-related events in patients with metastatic breast cancer
por: Idota, Ai, et al.
Publicado: (2016)

Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE Registry
por: Ohashi, Yasuo, et al.
Publicado: (2020)

Corrigendum to: Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE Registry
por: Ohashi, Yasuo, et al.
Publicado: (2020)

Time to Chemotherapy for Patients With Estrogen Receptor-Positive Breast Cancer and Cyclin-Dependent Kinase 4 and 6 Inhibitor Use
por: Endo, Yuka, et al.
Publicado: (2022)

Single-dose trastuzumab monotherapy achieved pathological complete response (pCR) in a patient with HER2-positive breast cancer: a case report
por: Isogai, Ayaka, et al.
Publicado: (2023)

Angiogenic Sprouting Requires the Fine Tuning of Endothelial Cell Cohesion by the Raf-1/Rok-α Complex
por: Wimmer, Reiner, et al.
Publicado: (2012)

From autoinhibition to inhibition in trans: the Raf-1 regulatory domain inhibits Rok-α kinase activity
por: Niault, Théodora, et al.
Publicado: (2009)

Rok po svém spuštění je obří urychlova LHC stále mimo provoz - eské noviny
Publicado: (2009)

How bacterial xenogeneic silencer rok distinguishes foreign from self DNA in its resident genome
por: Duan, Bo, et al.
Publicado: (2018)

Trendy I Oczekiwania w Badaniach Podłoża Molekularnego Encefalopatii Padaczkowych - Stan Na Rok 2017
por: Hoffman-Zacharska, Dorota, et al.
Publicado: (2018)

The DEAD-Box Protein Rok1 Coordinates Ribosomal RNA Processing in Association with Rrp5 in Drosophila
por: Chen, Jie, et al.
Publicado: (2022)

The B. subtilis Rok protein is an atypical H-NS-like protein irresponsive to physico-chemical cues
por: Erkelens, Amanda M, et al.
Publicado: (2022)

Impact of intrinsic subtype on predicting axillary lymph node metastasis in breast cancer
por: SAWAKI, MASATAKA, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_etpuv4hnvirjf2lnor5tfmsbjc